publication date: May. 10, 2019

House committee advances FY2020 funding bill giving NIH a $2 billion raise

By Claire Dietz

The House Committee on Appropriations May 8 approved a spending bill that gives NIH $41.1 billion, a $2 billion increase over the current level. The bill passed on a vote of 30 to 23.

The Subcommittee on Labor, HHS and Education of the House Committee on Appropriations April 30 marked up the initial version of the spending bill (The Cancer Letter, May 8).

Since FY2016, the NIH appropriations grew by $2 billion to $3 billion increments, which altogether have added up to a 30% increase. If the House bill is enacted, NCI is slated to receive an estimated increase of up to $280 million in FY2020.

“Today’s vote is an important step toward ensuring the National Institutes of Health and the National Cancer Institute are appropriately funded and can continue making progress on new and improved ways to prevent, detect and treat cancer,” Lisa Lacasse, president of the American Cancer Society Cancer Action Network, said in a statement May 8.

“The additional $2 billion included in this FY 2020 appropriations bill reflects the bipartisan dedication of committee chairwoman Rep. Nita Lowey (D-NY) and ranking member Rep. Kay Granger (R-TX) along with subcommittee chairwoman Rep. Rosa DeLauro (D-CT) and ranking member Rep. Tom Cole (R-OK) to the importance of medical research.

“Consistent and continuous funding increases for NIH and NCI along with increased funding for the Centers of Disease Control and Prevention and the Office on Smoking and Health is essential to that effort.”

The bill also increases funding by approximately $40 million each for the Centers for Disease Control and Prevention … Continue reading House committee advances FY2020 funding bill giving NIH a $2 billion raise

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.